PURPOSE: To assess the effects of the unabsorbed fraction of an orally administered antimicrobial drug which enters the colon on the emergence of resistance among the natural microflora, a phenomenon largely overlooked so far despite its clinical importance, especially when sustained release formulations are used. METHODS: Effects of an orally administered model beta-lactam antibiotic (amoxicillin) on emergence of resistant bacteria were assessed using a microbiological assay for qualitative and quantitative determination of resistant bacteria in fecal samples of rats following gastric administration of the drug to rats for 4 consecutive days. Time- and site-controlled administration of a beta-lactamase to the rat colon was assessed as a potential strategy for prevention the emergence of resistant bacteria following oral administration of incompletely absorbed antimicrobials. RESULTS: Emergence of resistant bacteria was demonstrated following oral administration of amoxicillin to rats, whereas de-activation of the beta-lactam prior to entering the colon, by infusion of a beta-lactamase into the lower ileum, was shown to prevent the emergence of resistant colonic bacteria. CONCLUSIONS: This study illustrates the need to consider the emergence of antimicrobial resistance as a goal equally important to microbiological and clinical cure, when designing oral sustained-release delivery systems of antimicrobial drugs.
PURPOSE: To assess the effects of the unabsorbed fraction of an orally administered antimicrobial drug which enters the colon on the emergence of resistance among the natural microflora, a phenomenon largely overlooked so far despite its clinical importance, especially when sustained release formulations are used. METHODS: Effects of an orally administered model beta-lactam antibiotic (amoxicillin) on emergence of resistant bacteria were assessed using a microbiological assay for qualitative and quantitative determination of resistant bacteria in fecal samples of rats following gastric administration of the drug to rats for 4 consecutive days. Time- and site-controlled administration of a beta-lactamase to the rat colon was assessed as a potential strategy for prevention the emergence of resistant bacteria following oral administration of incompletely absorbed antimicrobials. RESULTS: Emergence of resistant bacteria was demonstrated following oral administration of amoxicillin to rats, whereas de-activation of the beta-lactam prior to entering the colon, by infusion of a beta-lactamase into the lower ileum, was shown to prevent the emergence of resistant colonic bacteria. CONCLUSIONS: This study illustrates the need to consider the emergence of antimicrobial resistance as a goal equally important to microbiological and clinical cure, when designing oral sustained-release delivery systems of antimicrobial drugs.
Authors: C William Wester; Lakshmi Durairaj; Arthur T Evans; David N Schwartz; Shahid Husain; Enrique Martinez Journal: Arch Intern Med Date: 2002-10-28
Authors: Amnon Hoffman; David Stepensky; Eran Lavy; Sara Eyal; Eytan Klausner; Michael Friedman Journal: Int J Pharm Date: 2004-06-11 Impact factor: 5.875
Authors: Xianhua Cao; Seth T Gibbs; Lanyan Fang; Heather A Miller; Christopher P Landowski; Ho-Chul Shin; Hans Lennernas; Yanqiang Zhong; Gordon L Amidon; Lawrence X Yu; Duxin Sun Journal: Pharm Res Date: 2006-08 Impact factor: 4.200
Authors: W H Barr; E M Zola; E L Candler; S M Hwang; A V Tendolkar; R Shamburek; B Parker; M D Hilty Journal: Clin Pharmacol Ther Date: 1994-09 Impact factor: 6.875
Authors: Jaana Harmoinen; Silja Mentula; Matti Heikkilä; Michel van der Rest; Päivi J Rajala-Schultz; Curtis J Donskey; Rafael Frias; Pertti Koski; Nina Wickstrand; Hannele Jousimies-Somer; Elias Westermarck; Kai Lindevall Journal: Antimicrob Agents Chemother Date: 2004-01 Impact factor: 5.191